Medifast (MED) Earnings Analysis

Medifast (MED) next reports earnings on 2026-08-03, consensus EPS -0.68 USD. Last quarter (2026-05-04) it beat with EPS -0.19 USD vs -0.55 USD est (+65.5%). It has beaten estimates in 6/8 recent quarters (75%). Trailing P/E -5.36.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does MED next report earnings?

Next earnings date2026-08-03
Consensus EPS estimate-0.68 USD
Revenue estimate0.07B

MED earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-04-0.19 USD-0.55 USD+65.5%Beat
2026-02-17-0.55 USD-0.76 USD+27.6%Beat
2025-11-03-0.21 USD-0.01 USD-2000%Miss
2025-08-040.04 USD-0.3 USD+113.3%Beat
2025-04-28-0.11 USD-0.07 USD-57.1%Miss
2025-02-180.1 USD-0.16 USD+162.5%Beat
2024-11-040.35 USD-0.15 USD+333.3%Beat
2024-08-050.92 USD0.36 USD+155.6%Beat

Beat rate: 6/8 (75%) over reported quarters with consensus data.

MED valuation and analyst view

Trailing P/E-5.36
Trailing EPS-1.81919 USD
Price / book0.54
Dividend yield0.00%
Market cap0.11B
Analyst consensusHold (4 buy / 6 hold / 2 sell)
Avg price target12 USD

Related research pages

Frequently asked questions

When is Medifast (MED)'s next earnings date?

Medifast is next scheduled to report on 2026-08-03, with a consensus EPS estimate of -0.68 USD and revenue estimate of 0.07B.

Did MED beat earnings last quarter?

In its 2026-05-04 report, MED posted EPS of -0.19 USD versus a -0.55 USD estimate — a beat of 65.5%.

What is MED's earnings track record?

Over the last 8 reported quarters with consensus data, MED beat estimates 6 times (75%).

What is MED's current P/E ratio and EPS?

MED trades at a trailing P/E of -5.36 on trailing EPS of -1.8191895329820098 USD.

What do analysts rate MED?

Analyst consensus is "Hold" across 12 ratings (0 strong buy, 4 buy, 6 hold, 2 sell, 0 strong sell). Average 12-month price target: 12 USD.